THE IMPORTANCE OF S-REACTIVE PROTEIN, PROCALCITONIN, AND CYTOKINES IN DETERMINING THE PROSPECT OF SARS-COV-2-ASSOCIATED PNEUMONIA

Abstract

Coronavirus infection (COVID-19), considered an acute infectious disease caused by the SARS-CoV-2 virus, is characterized by activation of the hemostasis system. As a result of this, severe cases can develop ya ni coagulopathy. Whether COVID-19 is the direct cause of this condition or whether they occur with the development of an infectious process remains unclear for the time being. The frequency of occurrence of asymptomatic and clinically specific thrombotic, thromboembolic complications in COVID-19 remains uncertain. This condition is largely associated with difficulties in diagnosis. However, according to some data, patients with COVID-19 have a much higher frequency of venous and arterial thrombosis. In this case, the peculiarities of the course of the disease, the search for the factors that causes it and the interest in them from the point of view of study, aroused interest and gave rise to many munazaras.